Evaluation of neurological changes in secondary progressive multiple sclerosis patients treated with immune modulator MIS416: results from a feasibility study

BACKGROUND: While disease progression can be readily monitored in early stage relapsing multiple sclerosis (MS), it is more challenging for secondary progressive multiple sclerosis (SPMS). This advanced stage of disease has distinct pathophysiology due to compartmentalization of neuroinflammatory ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Webster, Gill A., Sim, Dalice A., La Flamme, Anne C., Mayo, Nancy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689160/
https://www.ncbi.nlm.nih.gov/pubmed/29177070
http://dx.doi.org/10.1186/s40814-017-0201-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689160/
https://www.ncbi.nlm.nih.gov/pubmed/29177070
http://dx.doi.org/10.1186/s40814-017-0201-4

Ejemplares similares